187 related articles for article (PubMed ID: 26497087)
21. Aqueous poly(amidoamine) dendrimer G3 and G4 generations with several interior cores at pHs 5 and 7: a molecular dynamics simulation study.
Kavyani S; Amjad-Iranagh S; Modarress H
J Phys Chem B; 2014 Mar; 118(12):3257-66. PubMed ID: 24588382
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive MR thermometry using paramagnetic lanthanide complexes of 1,4,7,10-tetraazacyclodoecane-alpha,alpha',alpha'',alpha'''-tetramethyl-1,4,7,10-tetraacetic acid (DOTMA4-).
Hekmatyar SK; Hopewell P; Pakin SK; Babsky A; Bansal N
Magn Reson Med; 2005 Feb; 53(2):294-303. PubMed ID: 15678553
[TBL] [Abstract][Full Text] [Related]
23. Macromolecular and dendrimer-based magnetic resonance contrast agents.
Bumb A; Brechbiel MW; Choyke P
Acta Radiol; 2010 Sep; 51(7):751-67. PubMed ID: 20590365
[TBL] [Abstract][Full Text] [Related]
24. Metallodendrimers and dendrimer nanocomposites.
Tang YH; Huang AY; Chen PY; Chen HT; Kao CL
Curr Pharm Des; 2011; 17(22):2308-30. PubMed ID: 21736548
[TBL] [Abstract][Full Text] [Related]
25. Xenon biosensor amplification via dendrimer-cage supramolecular constructs.
Mynar JL; Lowery TJ; Wemmer DE; Pines A; Fréchet JM
J Am Chem Soc; 2006 May; 128(19):6334-5. PubMed ID: 16683795
[TBL] [Abstract][Full Text] [Related]
26. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
27. PAMAM dendrimers conjugated with an uncharged gadolinium(III) chelate with a fast water exchange: the influence of chelate charge on rotational dynamics.
Polásek M; Hermann P; Peters JA; Geraldes CF; Lukes I
Bioconjug Chem; 2009 Nov; 20(11):2142-53. PubMed ID: 19883075
[TBL] [Abstract][Full Text] [Related]
28. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
[TBL] [Abstract][Full Text] [Related]
29. PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations.
Yang L; da Rocha SR
Mol Pharm; 2014 May; 11(5):1459-70. PubMed ID: 24679335
[TBL] [Abstract][Full Text] [Related]
30. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
Kobayashi H; Kawamoto S; Choyke PL; Sato N; Knopp MV; Star RA; Waldmann TA; Tagaya Y; Brechbiel MW
Magn Reson Med; 2003 Oct; 50(4):758-66. PubMed ID: 14523962
[TBL] [Abstract][Full Text] [Related]
31. Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents.
Laus S; Sour A; Ruloff R; Tóth E; Merbach AE
Chemistry; 2005 May; 11(10):3064-76. PubMed ID: 15776490
[TBL] [Abstract][Full Text] [Related]
32. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.
Leiro V; Garcia JP; Tomás H; Pêgo AP
Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129
[TBL] [Abstract][Full Text] [Related]
33. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
[TBL] [Abstract][Full Text] [Related]
34. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates.
Bryant LH; Brechbiel MW; Wu C; Bulte JW; Herynek V; Frank JA
J Magn Reson Imaging; 1999 Feb; 9(2):348-52. PubMed ID: 10077036
[TBL] [Abstract][Full Text] [Related]
36. Towards longitudinal mapping of extracellular pH in gliomas.
Huang Y; Coman D; Herman P; Rao JU; Maritim S; Hyder F
NMR Biomed; 2016 Oct; 29(10):1364-72. PubMed ID: 27472471
[TBL] [Abstract][Full Text] [Related]
37. A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient and biocompatible gene delivery vector.
Zeng X; Pan S; Li J; Wang C; Wen Y; Wu H; Wang C; Wu C; Feng M
Nanotechnology; 2011 Sep; 22(37):375102. PubMed ID: 21852739
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
39. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
[TBL] [Abstract][Full Text] [Related]
40. Imaging the intratumoral-peritumoral extracellular pH gradient of gliomas.
Coman D; Huang Y; Rao JU; De Feyter HM; Rothman DL; Juchem C; Hyder F
NMR Biomed; 2016 Mar; 29(3):309-19. PubMed ID: 26752688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
